LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of ($0.35), $0.11 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $173.8 million versus the consensus estimate of $171.36 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2021 revenue of $668-678 million, versus the consensus of $670 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.